In cancer immunotherapy research,
Science is changing the score

Starting with the PD-L1 pathway, Genentech is taking a dynamic approach to research by exploring how to modulate the antitumor immune response

Starting with the PD-L1 pathway, Genentech is taking a dynamic approach to research

Find out more

Exploring Cancer Immunotherapy Research

Discover the science behind our research

Explore now

Immunogenic Cancers

View which tumor types are a focus of exploration

View now

Researching Immunotherapy pathways: PD-L1

See how the PD-L1 pathway enables cancer immune evasion

Learn more

Resources

View downloadable content summaries, expert videos, and external clinical trial support sites

Search now

Register For Updates

Stay connected to research, news, and updates

Register now

Expert videos

Learn more about the PD‑L1 pathway and PD‑L1 expression from leading experts, doctors Roy Herbst and Ken Bloom.

Watch now